- Home
- VLT vs NSPR Comparison
VLT vs NSPR Comparison
Compare VLT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VLT | NSPR |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.5M | 81.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VLT | NSPR |
|---|---|---|
| Price | $11.14 | $1.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 22.9K | ★ 57.4K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 10.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | ★ $7,779,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | N/A | $75.45 |
| P/E Ratio | $16.69 | ★ N/A |
| Revenue Growth | N/A | ★ 14.04 |
| 52 Week Low | $9.29 | $1.59 |
| 52 Week High | $10.93 | $3.80 |
Technical Indicators
Market Signals| Indicator | VLT | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 54.45 | 43.33 |
| Support Level | $11.06 | $1.89 |
| Resistance Level | $11.12 | $2.15 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 95.00 | 25.61 |
Price Performance
Historical ComparisonAbout VLT Invesco High Income Trust II
Invesco High Income Trust II is a diversified, closed-end management investment company. Its investment objective is to provide high current income, while seeking to preserve shareholders' capital through investment in a professionally managed, diversified portfolio of high-income producing fixed-income securities.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.